- GBP/USD benefits from the broad US dollar weakness.
- The UK PM announces the most stringent rules post World War II to tame the coronavirus after the death toll reached 335.
- US Senate nears the COVID-19 Bill while the Fed announced unlimited QE the previous day.
- The preliminary PMI data is likely to portray the first impressions of the deadly virus on the key activities.
While benefiting from the broad US dollar weakness, GBP/USD registers 0.75% gains to 1.1635 while heading into the London open on Tuesday. The Cable seems to pay a little heed to domestic coronavirus (COVID-19) concerns amid the broad pullback in the greenback. However, traders are still cautious ahead of the first impressions of the deadly virus on the key activity numbers from the UK and the US.
The US Senate failed to pass the much-awaited $2 trillion COVID-19 Bill but the Republicans are hopeful for the deal to be rolled out soon. Late on Monday, the US Federal Reserve (Fed) announced unlimited Quantitative Easing (QE) to combat the disease.
It’s worth mentioning that the global death toll surges past-16,380 with more than 335 in the UK. While identifying the threat of the outbreak, the British PM Boris Johnson announced the strictest measures, including fines on the public and shops during the lockdown, to push the people to stay at home.
Additionally, the UK’s emergency coronavirus legislation will also reach the House of Lords for further debate before turning into the law some time by the end of the week.
Risk-tone remains positive with the US 10-year treasury yields, S&P 500 Futures and Asian stocks are all on their ways to recover the latest losses.
While the headline Manufacturing and Services PMIs from the UK and the US are likely to slip into the contraction phase, with readings below 50.00. However, TD Securities cite the lag in the closure of the British firms to help the Cable while going forward.
Other than the activity numbers, coronavirus headlines and updates concerning the US package will also be important to watch.
A lower high formation on the daily chart, coupled with oversold RSI, suggests gradual recoveries towards Friday’s top near 1.1935.
Additional important levels
|Today last price||1.1637|
|Today Daily Change||91 pips|
|Today Daily Change %||0.79%|
|Today daily open||1.1546|
|Previous Daily High||1.1715|
|Previous Daily Low||1.1447|
|Previous Weekly High||1.24|
|Previous Weekly Low||1.1412|
|Previous Monthly High||1.3204|
|Previous Monthly Low||1.2726|
|Daily Fibonacci 38.2%||1.1549|
|Daily Fibonacci 61.8%||1.1612|
|Daily Pivot Point S1||1.1424|
|Daily Pivot Point S2||1.1302|
|Daily Pivot Point S3||1.1156|
|Daily Pivot Point R1||1.1691|
|Daily Pivot Point R2||1.1837|
|Daily Pivot Point R3||1.1959|
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.